share_log

復星醫藥:中國證券監督管理委員會批准有關H股或╱及H股可轉換債券之潛在發行

FOSUN PHARMA: APPROVAL FROM CHINA SECURITIES REGULATORY COMMISSION IN RELATION TO POSSIBLE ISSUANCE OF H SHARE OR/AND H SHARE CONVERTIBLE BONDS

香港交易所 ·  Apr 6, 2023 09:29
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more